Waltham, MA, United States of America

Inder Kaul

USPTO Granted Patents = 4 


 

Average Co-Inventor Count = 4.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2014-2017

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Inder Kaul: Innovator in Therapeutic Treatments

Introduction

Inder Kaul is a notable inventor based in Waltham, MA (US). He has made significant contributions to the field of medicine, particularly in the development of therapeutics for severe conditions such as sepsis. With a total of four patents to his name, his work is recognized for its potential impact on patient care.

Latest Patents

Among his latest patents is a medicament designed for the therapeutic treatment and improvement of sepsis. This medicament targets patients suffering from severe sepsis accompanied by one or more organ dysfunctions. It specifically addresses cases where the International Normalized Ratio (INR) of a plasma specimen obtained from the patient exceeds 1.4. The active ingredient in this innovative treatment is thrombomodulin, which plays a crucial role in the therapeutic process.

Career Highlights

Inder Kaul is currently associated with Asahi Kasei Pharma Corporation, where he continues to advance his research and development efforts. His work is characterized by a commitment to improving therapeutic options for critical health conditions.

Collaborations

Inder collaborates with esteemed colleagues in his field, including Kazuhisa Tsuruta and Yoshikazu Aoki. These partnerships enhance the scope and effectiveness of his research initiatives.

Conclusion

Inder Kaul's contributions to the field of therapeutic treatments, particularly for sepsis, underscore his role as an influential inventor. His innovative approaches and collaborations continue to pave the way for advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…